News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

New AI-Driven Model Could Revolutionize Conservation Efforts for Endangered Species
News Release

BALTIMORE, MD, May 8, 2025 – A new study published in the INFORMS journal Management Science introduces a data-driven strategy that is already beginning to change the way conservationists locate and protect endangered species in the U.S., which can be adopted worldwide.

Read More
Items to Stock Up on Before Trump's Tariffs Take Effect
Media Coverage

With sweeping new tariffs on Chinese-made products set to take effect this summer, Americans are being urged to prepare for price hikes on everyday goods. President Donald Trump's reinstated trade policies are expected to affect a wide swath of consumer imports, including electronics, furniture, appliances, and baby gear. Retail experts are advising shoppers to act before the tariffs hit and prices rise.

Read More
Can You Fly Without a REAL ID After May 7 Deadline? What To Know
Media Coverage

The time has come: REAL ID will finally be implemented in less than one week, about 20 years after it was initially proposed.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Gov. Kemp to give update on COVID-19

Gov. Kemp to give update on COVID-19

WGXA-TV, March 16, 2021

Gov. Brian Kemp is set to give an update on distributing the coronavirus vaccine in Georgia. Kemp and other state leaders are scheduled to speak starting at 4 p.m. from the State Capitol.

How do mRNA vaccines work - and why do you need a second dose? 5 essential reads

How do mRNA vaccines work - and why do you need a second dose? 5 essential reads

The Telegraph, March 16, 2021

Tens of millions of people across the U.S. have received a coronavirus vaccine. So far, the majority of doses have been either the Moderna or Pfizer vaccine, both of which use mRNA to generate an immune response. These gene-based vaccines have been in the works for decades, but this is the first time they have been used widely in people.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine